Using an appointment-based medication synchronization program can improve adherence rates among patients taking chronic medications, according to a new study published in the Journal of Managed Care & Specialty Pharmacy.
Using an appointment-based medication synchronization (ABMS) program can improve adherence rates among patients taking chronic medications, according to a new study published in the Journal of Managed Care & Specialty Pharmacy.
Researchers from Virginia Commonwealth University School of Pharmacy compared patients receiving ABMS with patients receiving usual care. Patients were included in the study if they were taking medications in 1 of 6 categories: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers; beta blockers; dihydropyridine calcium channel blockers; thiazide diuretics; metformin; and statins.
“An ABMS program in a community pharmacy setting was associated with higher rates of adherence and persistence for patients who had been taking chronic medications for at least 6 months,” the authors wrote.
Patients in the ABMS program experienced 3 actions: synchronization of medications so refills come due on a single day of the month; a monthly call from the pharmacy to the patient or family caregiver; and a scheduled appointment to pick up medications at the pharmacy and speak with the pharmacist if necessary.
The patients enrolled had been taking their chronic medications for at least 6 months. This patient population was chosen because nonadherence is more likely to occur in patients filling new prescriptions, and approximately half of patients discontinue therapy in the first 6 months.
The researchers found that participants in the ABMS program experienced adherence rates of 55% to 84%, depending on medication class, while participants with usual care only experience adherence rates of 37% to 62%. Overall, the odds of adherence were 2.3 to 3.6 times greater with ABMS. Usual care participants also became nonpersistent more often.
“This study shows that ABMS programs can improve medication adherence and persistence for patients who are newly prescribed or currently taking chronic medications,” the authors concluded.
In addition to clinical benefits, the findings about the ABMS program can have financial implications for health plans as improving adherence can help Medicare Advantage plans improve their star ratings, which in turn makes them eligible for bonuses and rebates, the researchers explained.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More